XML 61 R54.htm IDEA: XBRL DOCUMENT v3.25.3
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 32,533 $ 30,066 $ 80,940 $ 76,331
Interest expense, net 4,681 5,210 13,137 14,711
Depreciation and amortization 12,941 15,173 64,243 44,067
Share-based compensation expense 7,181 6,531 21,474 25,290
Foreign exchange impact 571 (1,176) (3,224) 1,263
SeaSpine merger-related costs 126 2,616 6,142 12,992
Restructuring costs and impairments related to M6 product lines 6   15,485  
Strategic investments 227 39 4,094 470
Acquisition-related fair value adjustments (427) 5,017 (1,800) 15,351
Interest and loss on investments (10) 3,567 (41) 5,120
Litigation and investigation costs 21,548 8,335 28,619 10,318
Employee retention credit 0   (2,854)  
Succession charges   505   8,061
Loss before income taxes (22,262) (26,637) (88,618) (94,165)
Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 30,642 26,796 76,591 74,373
Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 1,891 3,270 4,349 1,958
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 205,634 196,606 602,401 583,834
Non-GAAP cost of sales 56,627 56,569 168,162 168,696
Non-GAAP Sales, general, and administrative 113,667 105,650 339,285 327,526
Non-GAAP Research and development 13,815 17,130 42,726 54,049
Other segment expenses (benefits) 2,186 136 8,924 (73)
Non-GAAP Depreciation, amortization, and share-based compensation expense 13,194 12,945 37,636 42,695
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 172,063 166,104 505,723 495,431
Non-GAAP cost of sales 44,016 46,140 131,414 134,952
Non-GAAP Sales, general, and administrative 93,288 89,052 282,995 273,406
Non-GAAP Research and development 11,051 14,042 34,436 44,106
Other segment expenses (benefits) 2,223 98 9,130 (39)
Non-GAAP Depreciation, amortization, and share-based compensation expense 9,157 10,024 28,843 31,367
Operating Segments [Member] | Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 33,571 30,502 96,678 88,403
Non-GAAP cost of sales 12,611 10,429 36,748 33,744
Non-GAAP Sales, general, and administrative 20,379 16,598 56,290 54,120
Non-GAAP Research and development 2,764 3,088 8,290 9,943
Other segment expenses (benefits) (37) 38 (206) (34)
Non-GAAP Depreciation, amortization, and share-based compensation expense 4,037 2,921 8,793 11,328
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 7,951 $ 10,886 $ 24,283 $ 32,853